Glencore International Plc (GLNCY) 4.8100

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Glencore International Plc (GLNCY) 4.8100 $GLNCY

Industrial Metals Stock Outlook - Aug 2016
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 5:02PM CDT
Industrial Metals Stock Outlook - Aug 2016
AA: 10.05 (-0.45), BHP: 32.06 (-0.63), VALE: 5.70 (-0.17), FCX: 11.15 (-0.83), RIO: 31.54 (-0.59)

Glencore Canada Corporation Announces Application to Cease to Be a Reporting Issuer in Canada
Marketwired - Wed Aug 10, 3:00PM CDT
TORONTO, ON--(Marketwired - August 10, 2016) - Glencore Canada Corporation ("GCC" announced today that it has applied to the securities regulatory authorities in each of the provinces and territories of Canada for a decision deeming it to have ceased to be a reporting issuer in such jurisdictions. GCC has two series of debt securities outstanding, being US$250 million aggregate principal amount of 5.5% unsecured notes due in June 2017 and US$250 million aggregate principal amount of 6.2% unsecured notes due in June 2035 (collectively, the "Notes". The Notes are fully and unconditionally guaranteed by Glencore plc ("Glencore", Glencore (Schweiz) AG and Glencore International AG. Glencore International Investments Limited is also a co-obligor of the Notes.

Emerging Markets to Drive the Future of Coal
Adam Arif - Zacks Investment Research - Thu Jun 23, 4:56PM CDT
Despite anticipated trends favoring clean energy use, global developments suggest coal will continue to take up a substantial portion of the global energy space.
CNX: 17.78 (-0.16), TCK: 15.77 (-0.46), BHP: 32.06 (-0.63), XOM: 87.98 (+0.26), RIO: 31.54 (-0.59)


Copper mine developer fires back at US Forest Service
By STEVE KARNOWSKI - AP - Tue Jun 14, 4:27PM CDT
MINNEAPOLIS (AP) — A company that wants to build an underground copper-nickel mine near the Boundary Waters Canoe Area Wilderness in northeastern Minnesota criticized the U.S. Forest Service on Tuesday for saying it may deny renewal of the mineral leases needed for the $2.8 billion project near Ely.

5 Stocks to Dump as China Crumbles
Zacks Equity Research - Zacks Investment Research - Wed Jan 13, 2:03PM CST
As copper prices fall amid China fears, we suggest 5 copper stocks to dump given their bearish Zacks Rank and downward estimate revisions.
TCK: 15.77 (-0.46), BHP: 32.06 (-0.63), VALE: 5.70 (-0.17), FCX: 11.14 (-0.84), HBM: 4.41 (-0.32), BVN: 13.26 (-1.12), RIO: 31.54 (-0.59)

SunCoke Energy (SXC) Reveals Weak Q4 & 2015 Production
Zacks Equity Research - Zacks Investment Research - Mon Jan 11, 3:30PM CST
SunCoke Energy Inc. (SXC) announced domestic coke production for the fourth quarter and the full year of 1.03 million tons (Mt) and 4.12 Mt, respectively, witnessing a decline of 53,000 tons and 52,000 tons year over year.
SXCP: 12.37 (-0.18), SXC: 6.54 (-0.29), CLD: 3.68 (-0.16)

CNX Coal Resources Cuts '16 Sales Outlook amid Global Rout
Zacks Equity Research - Zacks Investment Research - Thu Jan 07, 3:40PM CST
CNX Coal Resources LP (CNXC) lowered its coal sales expectation for 2016 amid the slump in commodity prices the world over.
CNXC: 12.80 (+0.05), CNX: 17.78 (-0.16), CLD: 3.68 (-0.16)

Silver Wheaton Corp.'s Best Moves in 2015
Dan Caplinger, The Motley Fool - Motley Fool - Mon Dec 28, 1:41PM CST
Image: Silver Wheaton. Gold and silver streaming specialist Silver Wheaton has had a tough time in 2015, as prices for precious metals have suffered from continued weakness in the commodities markets. Nevertheless, Silver Wheaton has done what...
SLW: 26.21 (-2.28)

Industrial Metals Stock Outlook - Jan 2016
Zacks Equity Research - Zacks Investment Research - Wed Dec 23, 1:08PM CST
Industrial Metals Stock Outlook - Jan 2016
AA: 10.05 (-0.45), BHP: 32.06 (-0.63), VALE: 5.70 (-0.17), FCX: 11.14 (-0.84), RIO: 31.54 (-0.59)

What If Silver Wheaton Doesn't Help Save Glencore?
Reuben Gregg Brewer, The Motley Fool - Motley Fool - Sat Oct 31, 11:15AM CDT
Silver Wheaton Corp. (USA) has seen its name come up several times in reference to troubled commodity giant Glencore  ( NASDAQOTH: GLNCY) . Why? Because Glencore needs money and Silver Wheaton's whole business is about giving money to miners in...
FNV: 71.63 (-4.77), SLW: 26.21 (-2.28), RGLD: 75.70 (-7.03)

3 Stocks in the Metals Mining Sector We'd Still Buy
Neha Chamaria, Alex DUMORTIER, CFA, and Tyler Crowe, The Motley Fool - Motley Fool - Sun Oct 04, 6:02AM CDT
Investors in metal mining stocks have little to be excited about. Miners have seen their revenue and profits fall off a cliff as commodity prices continue to head lower, compelling many to delay or shelve big projects as they struggle to rein in...
BHP: 32.06 (-0.63), SLW: 26.21 (-2.28)

Glencore International Investments Limited has Become a Co-Obligor for Glencore Canada Corporation's Notes
Marketwired - Wed Sep 30, 3:02PM CDT
Glencore Canada Corporation ("GCC" today announced that Glencore International Investments Limited, an indirect wholly-owned subsidiary of Glencore plc, has become a co-obligor of the following senior debt of GCC previously (collectively, the "Notes": (i) US$250 million principal amount of 6.2% notes due June 15, 2035; (ii) US$250 million principal amount of 5.5% notes due June 15, 2017; and (iii) US$341 million principal amount of 6% notes due October 15, 2015.

Uncertainty Weighs Down On The Market – Markets This Morning
Dana Blankenhorn - Amigobulls - Wed Sep 30, 3:01AM CDT
Markets were down again yesterday, as uncertainty looms. Biotech and tech were down, while oil saw some gains. Markets are likely to remain subdued.
PBR: 9.16 (-0.10), VRX: 30.92 (-0.28), XOM: 87.98 (+0.26), AAPL: 108.22 (-0.63)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading